A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2

The COVID-19 pandemic has caused significant morbidity and mortality. There is an urgent need for serological tests to detect antibodies against SARS-CoV-2, which could be used to assess past infection, evaluate responses to vaccines in development, and determine individuals who may be protected fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Robert L., Huang, Yuting, Smetana, Heather, Gehrie, Eric A., Amukele, Timothy K., Tobian, Aaron A.R., Mostafa, Heba H., Wang, Zack Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959259/
https://www.ncbi.nlm.nih.gov/pubmed/33773139
http://dx.doi.org/10.1016/j.bbrc.2021.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959259/
https://www.ncbi.nlm.nih.gov/pubmed/33773139
http://dx.doi.org/10.1016/j.bbrc.2021.03.016

Ejemplares similares